00002-7678-01 — Ramucirumab 500 Mg/50ml IV Soln
Cite this view
HANK Price Transparency. (n.d.). RAMUCIRUMAB 500 MG/50ML IV SOLN (NDC 00002-7678-01) negotiated rates. PPMan price-transparency data, derived from CMS-required hospital MRFs. Retrieved , from http://ppman.hank.ai/transparency/code/00002-7678-01?code_type=NDC
“RAMUCIRUMAB 500 MG/50ML IV SOLN (NDC 00002-7678-01) negotiated rates.” HANK Price Transparency, http://ppman.hank.ai/transparency/code/00002-7678-01?code_type=NDC. Accessed .
“RAMUCIRUMAB 500 MG/50ML IV SOLN (NDC 00002-7678-01) negotiated rates,” HANK Price Transparency, accessed , http://ppman.hank.ai/transparency/code/00002-7678-01?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital machine-readable files (45 CFR 180). See methodology.
Usually $21,350–$24,294 (25th–75th percentile) across 2 hospitals · 1 payer.
“Negotiated” is the hospital’s negotiated facility rate for this NDC 00002-7678-01 — the consumer-grade median across the country. It covers the facility charge only; the surgeon’s and anesthesiologist’s fees are billed separately.
Per-month price trends are temporarily unavailable while we rebuild them on quality-filtered rates. The medians, percentiles, and per-hospital rates on this page are the quality-filtered figures.
Hospital rates (per row)
Showing consumer-grade rates only. Flagged / outlier filings (excluded from the medians above) are hidden — tick “Show flagged / outlier rates” to include them.
| Hospital | Payer | Plan | Negotiated rate | Gross | Cash | Observed | Source |
|---|---|---|---|---|---|---|---|
| ADVENTIST HEALTHCARE WHITE OAK MEDICAL CENTER Both | All Payers | All Plans | $19,878.34 | $19,878.34 | $19,480.77 | 2025-12-31 | MRF ↗ |
| COX MONETT HOSPITAL OutpatientFacility | None | — | — | $25,766.27 | $7,858.71 | 2026-04-24 | MRF ↗ |